These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 2652565

  • 1. Improved immunosuppression for secondary cadaver renal transplants (SCT) in high risk patients using quadruple immunosuppression with cyclosporine A (CsA) and rabbit anti-thymocyte globulin (RATG).
    DeMasi R, Thomas F, Cunningham P, Sash C, Clark G, Thomas J.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1729-31. PubMed ID: 2652565
    [No Abstract] [Full Text] [Related]

  • 2. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P, Ludwin D, Bear R, Aprile M, McQuarrie B, Poole R, White N.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract] [Full Text] [Related]

  • 3. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract] [Full Text] [Related]

  • 4. Sequential therapy with anti-thymocyte globulin and cyclosporine A in oligoanuric high-risk cadaveric kidney graft recipients.
    Valderrábano F, Anaya F, Robles NR, Jofré R.
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):75-8. PubMed ID: 3051597
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
    Rao KV, Andersen RC.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1652. PubMed ID: 2652540
    [No Abstract] [Full Text] [Related]

  • 7. Low-dose cyclosporin, prednisolone and anti-lymphocyte globulin immunosuppressive treatment in cadaveric kidney transplantation.
    Ono Y, Ohshima S, Fujita T, Kinukawa T, Matsuura O, Hirabayashi S, Takeuchi N.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1657-9. PubMed ID: 2652543
    [No Abstract] [Full Text] [Related]

  • 8. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG, Henry ML, Ferguson RM.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract] [Full Text] [Related]

  • 9. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
    Hiesse C, Neyrat N, Busson M, Bensadoun H, Lantz O, Bellamy J, Benoit G, Charpentier B, Fries D.
    Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483
    [No Abstract] [Full Text] [Related]

  • 10. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA, Aquino A, Ali A, Rodriguez R, Ali S.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract] [Full Text] [Related]

  • 11. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
    Maddux MS, Veremis SA, Pollak R, Mozes MF.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
    [Abstract] [Full Text] [Related]

  • 12. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients.
    Kupin W, Venkat KK, Oh HK, Dienst S, Levin NW.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1882-5. PubMed ID: 3547893
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression.
    Hoitsma AJ, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):12-3. PubMed ID: 3051578
    [No Abstract] [Full Text] [Related]

  • 16. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA, Toledo-Pereyra LH.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of initial versus delayed cyclosporine therapy in cadaveric renal transplant patients.
    Lewis R, Hodge E, Novick A, Steinmuller D, Streem S, Cunningham R, Swift C, Goormastic M, Badhwar K.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2088-92. PubMed ID: 3029914
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.